Stock listing
Oncolytics Biotech Inc.
Selected listing: ONCY · NASDAQ · USD · US
Oncolytics Biotech Inc. (NASDAQ:ONCY), Health Technology. Latest release Sep 29, 2026: Oncolytics Biotech® Announces Publication Demonstrating Pelareorep…
- Ticker
- NASDAQ:ONCY
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Oncolytics Biotech Inc.
Oncolytics Biotech Inc. is a public company traded under the ticker ONCY in the American market. Oncolytics focuses on developing innovative therapies for cancer treatment.
Latest news from Oncolytics Biotech Inc.
Oncolytics Biotech® Announces Publication Demonstrating Pelareorep Creates Immune Responses in Liver Cancer That Make Tumors Susceptible to Immunotherapy
September 29, 2026
Oncolytics Biotech® Announces Publication Demonstrating Pelareorep Creates Immune Responses in Liver Cancer That Make Tumors Susceptible to Immunotherapy
September 28, 2026
Oncolytics Biotech® Reports Accelerating Enrollment in Randomized REO 033 RAS-Mutant, MSS Colorectal Cancer Study
September 28, 2026
Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer
September 10, 2026
Oncolytics Biotech® Aligns with FDA on Registrational Path for Second-Line RAS-Mutant MSS Colorectal Cancer
August 18, 2026
Events
Research Oncolytics Biotech Inc.
Oncolytics Biotech Inc. company profile
View the public company page for Oncolytics Biotech Inc. on 6ix.
Oncolytics Biotech Inc. news
Read company news and market updates connected to Oncolytics Biotech Inc..
Oncolytics Biotech Inc. investor events
Find investor webinars, events, and replay context for Oncolytics Biotech Inc..